CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 40 enrolled
Drug / intervention
Capsaicin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00655811
NCT00655811Phase 4Completed

Ethnic Differences in Response to Topical Capsaicin: A Psychophysical Study on Healthy Subjects

Wake Forest University·interventional·Posted Apr 10, 2008·Updated Sep 10, 2018

In Brief

A Phase 4 clinical trial evaluating Capsaicin and Placebo moisturizing cream for Healthy. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The purpose of this research is to study how people respond differently to capsaicin in different racial groups and the effect it has on your pain levels. Capsaicin is a natural product made from hot chili peppers that is useful for treating the itch symptoms of skin disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 10, 2008
Enrollment StartFeb 1, 2008
Primary CompletionAug 1, 2008
Study CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 18.2 years ago

Interventions

Capsaicindrug

Topical application, 0.1%, Capzasin HP; Chattem Inc., Chattanooga, TN, U.S.A

Placebo moisturizing creamdrug

Placebo moisturizing cream with no active ingredient (Cetaphil; Galderma Laboratories LP, Fort Worth, TX, U.S.A.)